Biospecifics Tech Cp
(BSTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2002 | 04-2002 | 01-2002 | 10-2001 | 07-2001 | |
| Sales | 1,524 | 902 | 0 | 794 | 2,159 |
| Cost of Goods | 1,115 | 769 | N/A | 346 | 1,224 |
| Gross Profit | 409 | 133 | N/A | 448 | 935 |
| Operating Expenses | 1,196 | 1,871 | 0 | 1,349 | 1,028 |
| Operating Income | -672 | -969 | N/A | -554 | 131 |
| Interest Expense | 10 | 13 | 0 | 2 | 2 |
| Other Income | -4 | 17 | 0 | 1 | 7 |
| Pre-tax Income | -686 | -965 | 0 | -556 | 136 |
| Net Income Continuous | -668 | -938 | N/A | -546 | 130 |
| Net Income | $-668 | $-938 | $N/A | $-546 | $130 |
| EPS Basic Total Ops | -0.15 | -0.21 | N/A | -0.12 | 0.03 |
| EPS Basic Continuous Ops | -0.15 | -0.21 | N/A | -0.12 | 0.03 |
| EPS Diluted Total Ops | -0.15 | -0.21 | N/A | -0.12 | 0.03 |
| EPS Diluted Continuous Ops | -0.15 | -0.21 | N/A | -0.12 | 0.03 |
| EBITDA(a) | $-509 | $-1,296 | $N/A | $-263 | $285 |